A tick-borne parasite that ravages the red blood cells of dogs worldwide has been put under the microscope in one of the most comprehensive clinicopathological investigations of canine babesiosis to date. Researchers in Mizoram, a hilly state in Northeast India where the disease is endemic, systematically evaluated dogs naturally infected with Babesia gibsoni, combining diagnostic screening, blood profiling, abdominal ultrasound, and a battery of oxidant–antioxidant assays. Their findings, published in Acta Parasitologica, paint a detailed picture of a disease that is far more than a simple haemolytic anaemia: it is a multi-system disorder marked by liver injury, kidney stress, inflammation, fluid accumulation in the abdomen, and a measurable collapse of the red cell antioxidant defences that appears to fuel the severity of anaemia itself.

The diagnostic component of the study is a striking demonstration of how much the choice of test matters. Of 138 samples screened from dogs with suspected babesiosis, the rapid antibody test detected 43 infections, or 31.15 percent. Microscopic examination of blood smears, still the workhorse of parasitology in many clinics, found 70 positive cases, or 50.72 percent. But polymerase chain reaction, the molecular gold standard, confirmed 85 infections, or 61.59 percent of the cohort. The gap between the smear and PCR results is not academic; it means that in a substantial fraction of infected dogs, low-level parasitaemia escapes microscopic detection, allowing animals to remain infectious reservoirs while receiving no treatment. For practitioners in endemic regions, the study’s numbers argue strongly for PCR confirmation whenever clinical suspicion is high but the smear is negative.

Clinically, the infected dogs presented with a constellation of signs that will be familiar to any veterinarian in a Babesia-endemic area. The most consistent findings were depression and lethargy, inappetence or outright anorexia, and pyrexia. These are non-specific complaints, and the study underscores how easily early babesiosis can be mistaken for other febrile illnesses. What elevates the disease’s danger, however, is what happens beneath the surface, where the haematological and biochemical machinery of the body begins to fail in interlocking ways.

The haemogram revealed the classic hallmarks of B. gibsoni infection: anaemia from the destruction of parasitised red cells, thrombocytopaenia reflecting both immune-mediated platelet loss and consumption, and leukocytosis accompanied by neutrophilia and eosinophilia, signatures of a pronounced inflammatory response. On the biochemistry panel, the picture of systemic insult deepened. Dogs showed hypoproteinaemia and hypoalbuminaemia, consistent with protein loss and hepatic dysfunction, alongside hyperbilirubinaemia from red cell breakdown. Azotaemia pointed to renal compromise, while elevated levels of alanine aminotransferase and alkaline phosphatase indicated hepatocellular and cholestatic injury. Serum C-reactive protein, a sensitive acute phase marker, was markedly increased, confirming that the infection triggers a vigorous systemic inflammatory response. Taken together, the authors interpret these changes as evidence of multiple organ dysfunction syndrome, a condition more commonly associated with sepsis than with a haemoprotozoal infection.

Abdominal ultrasonography added an imaging dimension that few studies of this scale have incorporated. The most consistent ultrasonographic finding was splenomegaly, often accompanied by splenic parenchymal lesions, reflecting the spleen’s role as both a graveyard for damaged erythrocytes and a site of intense immunological activity. Perhaps more intriguing was the frequent detection of ascites, with the study noting that B. gibsoni infection is commonly associated with high-gradient ascites, defined by a serum-to-ascites albumin gradient above 1.1 g/dL, and ascitic fluid that was transparent to straw-coloured, characteristic of a transudate. In human medicine, the serum-ascites albumin gradient is a cornerstone of workup for abdominal fluid, distinguishing portal hypertension from inflammatory or malignant causes. Its application here suggests a degree of hepatic circulatory disturbance or hypoalbuminaemia-driven fluid shift that clinicians may be systematically under-recognising in babesiosis cases presenting with a distended abdomen.

The heart of the study, however, lies in its oxidant–antioxidant analysis, which elevates it from a descriptive clinicopathological survey to a mechanistic investigation. The researchers measured lipid peroxides, reduced glutathione, and total antioxidant capacity in the infected dogs and compared them against healthy controls. The results were unambiguous. Dogs with B. gibsoni infection had significantly higher lipid peroxide levels, the chemical fingerprints of free radical attack on cell membranes, and significantly lower concentrations of reduced glutathione and total antioxidant capacity, with all differences reaching statistical significance at P less than 0.001. The antioxidant machinery that normally shields red blood cells from oxidative attack had been overwhelmed.

The correlational analysis transforms this observation into an argument about causation. Red blood cell counts showed a strong negative correlation with lipid peroxide levels, with a correlation coefficient of −0.741 at P less than 0.01, meaning that dogs with the most oxidised red cells also had the fewest circulating red cells. Conversely, RBC counts correlated positively with reduced glutathione (r = 0.714) and total antioxidant capacity (r = 0.828), both at P less than 0.01. The interpretation is straightforward: erythrocyte peroxidation is not merely a bystander effect of infection but appears to be a contributing factor to the severity of the anaemia. When parasite-driven oxidative stress overwhelms the red cell’s enzymatic and non-enzymatic defences, lipid peroxidation renders the membrane rigid and recognisable to macrophages, which then clear the damaged cells, compounding the direct destruction caused by the parasite itself.

This mechanism fits neatly into a broader body of evidence on babesial pathogenesis. Earlier experimental work on B. gibsoni demonstrated enhanced erythrophagocytosis of oxidatively damaged infected erythrocytes and increased superoxide generation within parasitised cells, while studies in other piroplasms, including Babesia bigemina in cattle and ovine malignant theileriosis, have documented the same pattern of oxidant surge and antioxidant depletion. The Mizoram study is significant because it extends these mechanistic insights into a naturally infected, clinically diverse population, and because it ties them quantitatively to the parameter that ultimately matters most for survival, the red cell count. The oxidant–antioxidant imbalance, in other words, is not an epiphenomenon; it tracks with the disease’s most life-threatening consequence.

The clinical implications are potentially significant. If oxidative damage accelerates anaemia, then antioxidant therapy becomes a rational adjunct to antiprotozoal drugs such as atovaquone and azithromycin, which suppress but rarely eliminate B. gibsoni. Notably, the same research group has already reported a pilot study in which N-acetylcysteine, a glutathione precursor and well-known mucolytic drug, ameliorated oxidative stress and attenuated anaemia, the acute phase response, and hepatic injury in dogs with clinical B. gibsoni infection. The present study’s correlation data provide the pathophysiological rationale for that intervention, and they suggest that monitoring lipid peroxide and antioxidant indices could serve as a gauge of disease severity and treatment response. For a disease in which chronic carriers are the norm and complete parasitological cure is elusive, any strategy that protects the patient’s remaining red cells carries real value.

Beyond the therapy bench, the study carries a public health and diagnostic message for regions where dogs live alongside heavy tick pressure. The discordance between antibody detection, microscopy, and PCR means that a single negative test should never close the case, and the high prevalence of subclinical, PCR-positive infections in the cohort implies a large silent reservoir that perpetuates transmission. The ultrasound findings, particularly splenomegaly and high-gradient transudative ascites, offer clinicians bedside clues that babesiosis may be complicating patients thought to have primary hepatic or cardiac disease. As B. gibsoni continues its geographic spread, aided by dog movement, bite transmission, and expanding tick habitats, studies of this kind, grounded in real-world clinical populations and linking imaging, biochemistry, and redox biology, provide the comprehensive assessment framework that the field has needed to move from symptom management to mechanism-targeted care of one of the world’s most important canine parasitic diseases.

Subject of Research: Clinicopathological changes, abdominal ultrasound findings, and oxidative stress biomarkers in dogs naturally infected with Babesia gibsoni

Article Title: Comprehensive Assessment of Babesia gibsoni Infection in Dogs: Clinicopathological, Imaging, and Oxidative Stress Perspectives

Article References: Comprehensive Assessment of Babesia gibsoni Infection in Dogs: Clinicopathological, Imaging, and Oxidative Stress Perspectives. (n.d.). https://doi.org/10.1007/s11686-026-01421-y

Image Credits: AI Generated

DOI: 10.1007/s11686-026-01421-y

Keywords: Babesia gibsoni, canine babesiosis, dogs, anaemia, oxidative stress, lipid peroxidation, glutathione, total antioxidant capacity, thrombocytopaenia, ultrasonography, PCR diagnosis, India